Indian Immunologicals to Use Screening System from Genetix

Genetix has announced that Indian Immunologicals has become the first company on the Indian sub-continent to invest in a ClonePix FL system.

The system is used for the screening and selection of secretory cell lines, and can reduce the time and costs that are associated with recombinant protein generation. IIL will use the system to support their biotherapeutic research and development activities, and, subsequently, to help drive cost-effective manufacturing.